2,519
Views
11
CrossRef citations to date
0
Altmetric
Research Articles

Motives for non-adherence to colonoscopy advice after a positive colorectal cancer screening test result: a qualitative study

, , , , &
Pages 487-498 | Received 01 May 2020, Accepted 29 Aug 2020, Published online: 13 Nov 2020

References

  • GLOBOCAN. Number of new cases in 2018, both sexes, all ages; 2018 [accessed 2019 Oct 6]. Available from: https://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf.
  • Navarro M, Nicolas A, Ferrandez A, et al. Colorectal cancer population screening programs worldwide in 2016: An update. World J Gastroenterol. 2017;23(20):3632–3642.
  • Bevolkingsonderzoek darmkanker – Monitor 2017 [Population screening bowelcancer – monitor 2017]. Erasmus MC – NKI/AvL; 2018. Available from: https://www.rivm.nl/documenten/landelijke-monitoring-bevolkingsonderzoek-darmkanker-2017
  • Robertson DJ, Lee JK, Boland CR, et al. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US multi-society task force on colorectal cancer. Gastroenterology. 2017;152(5):1217.e3–1237.e3.
  • Li W, Zhao LZ, Ma DW, et al. Predicting the risk for colorectal cancer with personal characteristics and fecal immunochemical test. Medicine (Baltimore). 2018;97(18):e0529.
  • Rasmussen S, Haastrup PF, Balasubramaniam K, et al. Predictive values of colorectal cancer alarm symptoms in the general population: a nationwide cohort study. Br J Cancer. 2019;120(6):595–600.
  • Hamilton W. The CAPER studies: five case-control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients. Br J Cancer. 2009;101(Suppl 2):S80–S86.
  • Brenner H, Jansen L, Ulrich A, et al. Survival of patients with symptom- and screening-detected colorectal cancer. Oncotarget. 2016;7(28):44695–44704.
  • Bevolkingsonderzoek darmkanker – Monitor 2016 [Population screening bowelcancer – monitor 2016]. Erasmus MC – NKI/AvL; 2017. Available from: https://www.rivm.nl/documenten/landelijke-monitoring-bevolkingsonderzoek-darmkanker-2016
  • Landelijke Monitoring & Evaluatie Bevolkingsonderzoek Darmkanker - Rapportage 2014 [National monitoring & evaluation population screening bowel cancer – 2014 report]. Erasmus MC – NKI/AvL; 2015.
  • Bevolkingsonderzoek darmkanker – Monitor 2015 [Population screening bowelcancer – monitor 2015]. Erasmus MC – NKI/AvL; 2016. Available from: https://www.rivm.nl/documenten/landelijke-monitoring-bevolkingsonderzoek-darmkanker-2015
  • Gupta S, Halm EA, Rockey DC, et al. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med. 2013;173(18):1725–1732.
  • Martinsen RP, Morris CR, Pinheiro PS, Parikh-Patel A, et al. Colorectal cancer trends in California and the need for greater screening of hispanic men. Am J Prev Med. 2016;51(6):e155–e63.
  • Correia A, Rabeneck L, Baxter NN, et al. Lack of follow-up colonoscopy after positive FOBT in an organized colorectal cancer screening program is associated with modifiable health care practices. Prev Med. 2015;76(Supplement C):115–122.
  • Plumb AA, Ghanouni A, Rainbow S, et al. Patient factors associated with non-attendance at colonoscopy after a positive screening faecal occult blood test. J Med Screen. 2017;24(1):12–19.
  • Partin MR, Gravely AA, Burgess JF, et al. Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results. Cancer. 2017;123(18):3502–3512.
  • Morris S, Baio G, Kendall E, et al. Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: a retrospective analysis of the NHS Bowel Cancer Screening Programme. Br J Cancer. 2012;107(5):765–771.
  • Martin J, Halm EA, Tiro JA, et al. Reasons for lack of diagnostic colonoscopy after positive result on fecal immunochemical test in a safety-net health system. Am J Med. 2017;130(1):93.e1–93.e7.
  • Llovet D, Serenity M, Conn LG, et al. Reasons for lack of follow-up colonoscopy among persons with a positive fecal occult blood test result: a qualitative study. Am J Gastroenterol. 2018;113(12):1872–1880.
  • Bie AKL, Brodersen J. Why do some participants in colorectal cancer screening choose not to undergo colonoscopy following a positive test result? A qualitative study. Scand J Prim Health Care. 2018;36(3):262–271.
  • Bevolkingsonderzoek Midden-West. Veelgestelde vragen; 2017 [accessed 2018 Oct 6]. [most asked questions 2017] Available from: https://www.bevolkingsonderzoekmidden-west.nl/darmkanker/veelgestelde-vragen.
  • Bertels L. De ARCUS studie. Onderzoek naar redenen om geen darmonderzoek te ondergaan in het bevolkingsonderzoek darmkanker; 2016. [Investigation into reasons not to undergo a colonoscopy in the bowel cancer screening program]. [accessed 2018 Oct 6]. Available at: https://arcusstudie.nl/.
  • Dawson G, Crane M, Lyons C, et al. A qualitative investigation of factors influencing participation in bowel screening in New South Wales. Health Promot J Austr. 2016;27(1):48–53.
  • Aubin-Auger I, Mercier A, Lebeau JP, et al. Obstacles to colorectal screening in general practice: a qualitative study of GPs and patients. Fam Pract. 2011;28:670–676.
  • Jimbo M, Myers RE, Meyer B, et al. Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation. Ann Fam Med. 2009;7(1):11–16.
  • Dalton ARH. Incomplete diagnostic follow-up after a positive colorectal cancer screening test: a systematic review. J Public Health. 2017;40(1):e46–e58.
  • McLachlan SA, Clements A, Austoker J. Patients' experiences and reported barriers to colonoscopy in the screening context-a systematic review of the literature. Patient Educ Couns. 2012;86(2):137–146.
  • Wardle J, McCaffery K, Nadel M, et al. Socioeconomic differences in cancer screening participation: comparing cognitive and psychosocial explanations. Soc Sci Med. 2004;59(2):249–261.
  • Wardle J, Sutton S, Williamson S, et al. Psychosocial influences on older adults' interest in participating in bowel cancer screening. Prev Med. 2000;31(4):323–334.
  • Gili M, Roca M, Ferrer V, et al. Psychosocial factors associated with the adherence to a colorectal cancer screening program. Cancer Detect Prev. 2006;30(4):354–360.
  • Whynes DK, Frew EJ, Manghan CM, et al. Colorectal cancer, screening and survival: the influence of socio-economic deprivation. Pub Health. 2003;117(6):389–395.
  • Bonevski B, Randell M, Paul C, et al. Reaching the hard-to-reach: a systematic review of strategies for improving health and medical research with socially disadvantaged groups. BMC Med Res Methodol. 2014;14:42.
  • RIVM. Protocol voor de toelating en auditing van coloscopiecentra en endoscopisten [protocol for admission and auditing of colonoscopy centres and endoscopists] Bevolkingsonderzoek darmkanker; 2019. Available from: https://www.rivm.nl/documenten/protocol-toelating-en-auditing-coloscopiecentra-endoscopisten
  • Boeije H. Analyseren in kwalitatief onderzoek. [Analysing in qualitative research]. Amsterdam: Boom; 2016.
  • Bryman A. Social research methods. 3rd ed. Oxford: Oxford University Press; 2008.
  • National Institute for Public Health and the Environment (RIVM). [Implementation outline for population screening for colorectal cancer] Uitvoeringskader bevolkingsonderzoek darmkanker (in Dutch); 2019. Available from: https://www.rivm.nl/documenten/uitvoeringskader-bevolkingsonderzoek-darmkanker
  • Mannion R, Exworthy M. (Re) making the procrustean bed? Standardization and customization as competing logics in healthcare. Int J Health Policy Manag. 2017;6(6):301–304.
  • Pfaff H, Driller E, Ernstmann N, et al. Standardization and individualization in care for the elderly: proactive behavior through individualized standardization. Open Longev Sci. 2010;4:51–57.
  • Deandrea S, Molina-Barceló A, Uluturk A, et al. Presence, characteristics and equity of access to breast cancer screening programmes in 27 European countries in 2010 and 2014. Results from an international survey. Prev Med. 2016;91:250–263.
  • Timmermans S, Epstein S. A world of standards but not a standard world: toward a sociology of standards and standardization. Annu Rev Sociol. 2010;36(1):69–89.
  • Hamza S, Cottet V, Touillon N, et al. Long-term effect of faecal occult blood screening on incidence and mortality from colorectal cancer. Dig Liver Dis. 2014;46(12):1121–1125.
  • Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348(9040):1472–1477.
  • Kahi CJ, Imperiale TF, Juliar BE, et al. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol. 2009;7(7):770–775; quiz 11.
  • Camilloni L, Ferroni E, Cendales BJ, et al. Methods to increase participation in organised screening programs: a systematic review. BMC Public Health. 2013;13:464.
  • Woudstra AJ, Timmermans DRM, Uiters E, et al. Health literacy skills for informed decision making in colorectal cancer screening: perceptions of screening invitees and experts. Health Expect. 2018;21(3):636–646.
  • van der Heide I, Uiters E, Jantine Schuit A, et al. Health literacy and informed decision making regarding colorectal cancer screening: a systematic review. Eur J Public Health. 2015;25(4):575–582.
  • Rimer BK, Briss PA, Zeller PK, et al. Informed decision making: what is its role in cancer screening? Cancer. 2004;101(S5):1214–1228.
  • Douma LN, Uiters E, Verweij MF, et al. Autonomous and informed decision-making: the case of colorectal cancer screening. PLoS One. 2020;15(5):e0233308.
  • Hersch JK, Nickel BL, Ghanouni A, et al. Improving communication about cancer screening: moving towards informed decision making. Public Health Res Pract. 2017;27(3):2731728.
  • Rodriguez-Osorio CA, Dominguez-Cherit G. Medical decision making: paternalism versus patient-centered (autonomous) care. Curr Opin Crit Care. 2008;14(6):708–713.
  • Ploug T, Holm S, Brodersen J. To nudge or not to nudge: cancer screening programmes and the limits of libertarian paternalism. J Epidemiol Community Health. 2012;66(12):1193–1196.
  • Messina CR, Lane DS, Grimson R. Colorectal cancer screening attitudes and practices preferences for decision making. Am J Prev Med. 2005;28(5):439–446.
  • Garcia-Alonso FJ, Tejero MH, Cambrodon DB, et al. Knowledge acquired, satisfaction attained and attitudes towards shared decision making in colorectal cancer screening. Ann Gastroenterol. 2017;30(1):76–82.
  • Wunderlich T, Cooper G, Divine G, et al. Inconsistencies in patient perceptions and observer ratings of shared decision making: the case of colorectal cancer screening. Patient Educ Couns. 2010;80(3):358–363.
  • Lee SJ, O'Leary MC, Umble KE, et al. Eliciting vulnerable patients' preferences regarding colorectal cancer screening: a systematic review. Patient Prefer Adherence. 2018;12:2267–2282.
  • Gimeno Garcia AZ, Hernandez Alvarez Buylla N, Nicolas-Perez D, et al. Public awareness of colorectal cancer screening: knowledge, attitudes, and interventions for increasing screening uptake. ISRN Oncol. 2014;2014:425787.
  • Horshauge PM, Gabel P, Larsen MB, et al. The association between health literacy and colorectal cancer screening uptake in a publicly funded screening program in Denmark: cross-sectional study. Prev Med Rep. 2020;19:101132.
  • Menon U, Belue R, Wahab S, et al. A randomized trial comparing the effect of two phone-based interventions on colorectal cancer screening adherence. Ann Behav Med. 2011;42(3):294–303.